Gr Sarantis (SAR) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
23 Oct, 2025Executive summary
Nine-month 2025 net sales reached €448.5m, a 0.8% decrease year-over-year, with branded business outperforming private label.
Profitability improved, with EBITDA up 7.9% to €68.0m and EBIT up 7.4% to €51.7m compared to the same period last year.
Focus on cost discipline and operational excellence drove margin expansion despite softer demand in some markets.
International growth initiatives, including US expansion with new SKUs, are progressing and supporting future growth.
Financial highlights
Net sales for 9m 2025 were €448.5m, down 0.8% from €452.0m in 9m 2024.
EBITDA increased to €68.0m from €63.0m, a 7.9% rise year-over-year.
EBIT rose to €51.7m, up 7.4% from €48.1m in 9m 2024.
EBT reached €50.3m, a 10.9% increase from €45.4m in the prior year.
Net debt reduced to €4.9m as of September 30, 2025, from €12.4m a year earlier.
Outlook and guidance
Management remains focused on delivering full-year 2025 profitability guidance as previously indicated.
Priorities for the final quarter include disciplined execution, safeguarding profitability, and driving sustainable growth.
Latest events from Gr Sarantis
- EBITDA and net income surged in 2025, led by branded and beauty growth and global expansion.SAR
H2 202512 Mar 2026 - Record H1 sales and profit growth, fueled by Stella Pack and strong margin expansion.SAR
H1 202422 Jan 2026 - Record sales and profit growth in 2024, with further gains and investments forecast for 2025.SAR
H2 202424 Dec 2025 - Net profit up 20% to €29.2m on 0.5% sales growth, led by Beauty, Skin & Sun Care.SAR
H1 202512 Sep 2025 - Net sales surged 27.9% to €452.0m, with margin gains and strong Stella Pack integration.SAR
Q3 2024 TU13 Jun 2025